The risk of relapses in multiple sclerosis during systemic infections
- PMID: 16870812
- DOI: 10.1212/01.wnl.0000233834.09743.3b
The risk of relapses in multiple sclerosis during systemic infections
Abstract
Objectives: To assess the risk of multiple sclerosis (MS) relapses, MRI activity, and T cell responses during systemic infections (SI) in patients with MS.
Methods: The authors prospectively studied 60 patients with MS. Twenty patients were evaluated with sequential MRI on initial visit, and 2 and 12 weeks later. Blood samples were collected at first infection symptom and 2, 5, 12, and 24 weeks later, and production of IL-4, IL-10, IL-12, IFN-gamma, TNFalpha, VLA-4, LFA-1, MMP-9, and MMP-2 were measured after infectious antigens (Ag) stimulation.
Results: Increased risk of relapse and MRI activity were observed during SI. Numbers of IFN-gamma, TNFalpha, and IL-12 secreting cells, serum concentrations of MMP-9, and expression of VLA-4 and LFA-1 after PBMC viral or bacterial Ag stimulation were higher in samples collected during exacerbations associated to SI. Transwell analysis demonstrated that soluble factors produced during viral stimulation have little effect on myelin specific T cells activity. In contrast, PBMC viral stimulation in the presence of cognate myelin Ag induces maximal effector responses at 20 to 30 times lower than the Ag alone.
Conclusions: There was a significant association between systemic infections and risk of MS relapse, increased MRI activity, and T cells activation. Furthermore, infectious agents increased myelin specific T-cells sensitivity to cognate Ag.
Similar articles
-
Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection.J Neuroimmunol. 2007 Oct;190(1-2):177-89. doi: 10.1016/j.jneuroim.2007.08.011. Epub 2007 Oct 22. J Neuroimmunol. 2007. PMID: 17936916
-
Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.Mult Scler. 2011 Jun;17(6):672-80. doi: 10.1177/1352458510394397. Epub 2011 Jan 6. Mult Scler. 2011. PMID: 21212088
-
Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.Neurology. 2008 Dec 9;71(24):1948-54. doi: 10.1212/01.wnl.0000336918.32695.6b. Neurology. 2008. PMID: 19064876
-
[Rodent dissemination of diseases in Finland].Duodecim. 2005;121(3):295-302. Duodecim. 2005. PMID: 15787287 Review. Finnish. No abstract available.
-
The molecular basis of mycobacterial infection.Mol Aspects Med. 1996 Aug;17(4):383-454. doi: 10.1016/0098-2997(96)00002-7. Mol Aspects Med. 1996. PMID: 8934460 Review. No abstract available.
Cited by
-
Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis-A Real-World Scenario.Vaccines (Basel). 2024 Mar 12;12(3):296. doi: 10.3390/vaccines12030296. Vaccines (Basel). 2024. PMID: 38543930 Free PMC article.
-
Stressful life events and depression and fatigue in people with multiple sclerosis: a cross-sectional analysis of an international cohort.Acta Neurol Belg. 2024 Apr;124(2):457-466. doi: 10.1007/s13760-023-02390-z. Epub 2023 Sep 28. Acta Neurol Belg. 2024. PMID: 37770791 Free PMC article.
-
The association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort.Mult Scler J Exp Transl Clin. 2023 Sep 25;9(3):20552173231196992. doi: 10.1177/20552173231196992. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37767104 Free PMC article.
-
COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.Med Clin (Engl Ed). 2023 Mar 10;160(5):187-192. doi: 10.1016/j.medcle.2022.06.021. Epub 2023 Mar 3. Med Clin (Engl Ed). 2023. PMID: 36883067 Free PMC article.
-
Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis.Neurol Neuroimmunol Neuroinflamm. 2023 Feb 17;10(3):e200089. doi: 10.1212/NXI.0000000000200089. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 36807080 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous